For Investors & Transactions
AI Diligence Before Capital Is Committed
PreMetric helps investors assess whether AI-related value claims are credible, deployable, and defensible before investment, acquisition, or portfolio-level decisions are made.
AI value claim
Valuation, growth, margin, exit narrative
Assumption review
Deployment credibility, evidence quality
Capital exposure
Risk quantification, governance gaps
Investment decision record
Institutional defensibility
Point-in-time review. Produces a structured decision record.
AI claims are not the same as AI evidence
AI is increasingly being used to support valuation, growth, automation, margin expansion, product differentiation, and exit narratives. But in many cases, the assumptions behind those claims have not been tested against deployment reality, buyer adoption, governance requirements, data risk, operational dependencies, or regulatory friction.
Investors and transaction teams are frequently evaluating AI-enabled companies without a structured basis for assessing whether the AI upside is credible, deployable, and defensible — or whether it is a narrative that will collapse under the weight of procurement cycles, adoption friction, and enterprise governance requirements.
The gap between an AI claim and a deployable, governed AI capability is where capital exposure lives.
Valuation support
AI capability is used to justify a higher multiple or forward revenue assumption.
Growth narratives
Growth projections depend on AI-driven product adoption or market expansion.
Margin expansion
Cost reduction or margin improvement plans rely on AI automation that has not yet been deployed at scale.
Product differentiation
Competitive moat or pricing power is attributed to AI capabilities.
Automation narratives
Headcount reduction, workflow automation, or operational leverage assumes AI deployment that remains untested.
Exit and liquidity theses
Strategic or financial exit assumptions rest on AI-related value that has not been independently assessed.
What PreMetric provides
PreMetric provides structured, investor-focused AI reviews that produce a documented evidence chain around AI-related value claims. These are not advisory opinions or market assessments — they are institutional records designed to support capital discipline decisions.
Reviews are bounded, time-bounded, and concluded with a documented recommendation. They apply PreMetric's pre-deployment AI decision infrastructure to the specific investment or transaction context.
Investor AI Diligence Review
A structured assessment of AI-related value claims in an investment or acquisition target — covering deployment credibility, evidence quality, governance, and capital exposure.
AI-enabled business case assessment
Review of the assumptions and evidence chain behind a specific AI-driven business case embedded in a deal thesis.
Portfolio company AI readiness review
Assessment of an existing portfolio company's AI maturity, deployment readiness, and governance posture ahead of an exit or further capital deployment.
AI value/risk assessment for acquisition targets
A bounded review of AI-specific value claims, risks, and red flags in an M&A context — produced alongside or in addition to standard financial and legal diligence.
Portfolio AI exposure snapshot
A cross-portfolio assessment identifying where AI creates value, where assumptions are unsupported, and where governance, regulatory, or deployment risk may affect capital positions.
Questions PreMetric helps answer
Each review is structured around the questions that matter to investors, acquirers, and transaction teams — not technical performance benchmarks.
Capital discipline questions
- —Is the AI upside real or speculative?
- —Are the ROI assumptions credible and supported by deployment evidence?
- —Is the AI capability deployable in the target market at the assumed scale?
- —Are customer adoption assumptions realistic given procurement and governance friction?
- —Are there governance, data, model, procurement, or regulatory issues that could slow adoption?
- —Could AI-related weaknesses affect valuation, integration, exit potential, or follow-on financing?
- —Should the investment proceed, be modified, require conditions, or be paused pending further evidence?
When to use it
An Investor AI Diligence Review is most valuable before a capital commitment decision — when the AI-related evidence chain can still influence the terms, conditions, or outcome of the investment.
- —Before investing in an AI-enabled company
- —Before acquiring a company whose value story depends on AI
- —Before underwriting AI-driven margin expansion or automation assumptions
- —Before supporting a portfolio company's AI strategy or deployment plan
- —Before a follow-on financing round where AI claims affect valuation
- —Before approving AI-related capital expenditure across a portfolio
- —When a board, LP, lender, buyer, or acquirer requires a clearer evidence chain
Defined outputs
Every review concludes with a defined set of structured outputs. These are institutional records — not slide decks, not advisory summaries. They are designed to be used by investment committees, boards, LPs, and acquirers.
Investor AI diligence memo
A structured record of the diligence review, findings, and recommendation — suitable for IC, board, or LP use.
AI value/risk assessment
An assessment of where AI creates credible value, where claims are speculative, and where risk is material.
Deployment assumption review
Assessment of the assumptions underlying AI deployment claims and where they may fail under real conditions.
Capital exposure assessment
Quantification of capital at risk if AI value claims prove unsubstantiated or deployment fails.
Evidence-chain summary
The documented evidence chain supporting or qualifying AI-related value claims.
Governance and accountability gap analysis
Identification of governance, accountability, and regulatory gaps that could affect deployment or valuation.
Portfolio AI exposure snapshot
Cross-portfolio view of AI-related value positions, assumptions, and risk concentrations.
Proceed / modify / pause recommendation
A documented recommendation on whether to proceed to investment, modify terms, apply conditions, or pause pending further evidence.
When AI is material to the decision
The time to assess AI-related value claims is before capital is committed — not after the investment has closed, the acquisition has completed, or the thesis has been presented to LPs.
PreMetric works with investors, funds, acquirers, and transaction teams where AI is a material component of valuation, growth assumptions, diligence, portfolio performance, or capital allocation decisions.
This is not a continuous relationship or a monitoring service. It is a structured, bounded review triggered by a defined capital decision — producing documented outputs that can be used by investment committees, boards, and governance bodies.